FDA approves Instylla’s Embrace hydrogel embolic for peripheral arterial bleeds

FDA approves an expanded indication for Instylla’s Embrace hydrogel embolic to treat peripheral arterial bleeds; a federal judge strikes CMS’s narrowed medically frail Medicaid exemption; and DOL finalizes its PBM fee-disclosure rule.